A detailed history of Telemetry Investments, L.L.C. transactions in Eiger Bio Pharmaceuticals, Inc. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 345,000 shares of EIGR stock, worth $3.28 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
345,000
Previous 178,500 93.28%
Holding current value
$3.28 Million
Previous $1.34 Million 69.72%
% of portfolio
0.64%
Previous 1.72%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.02 - $7.48 $169,830 - $1.25 Million
166,500 Added 93.28%
345,000 $407,000
Q3 2022

Nov 17, 2022

SELL
$6.04 - $9.66 $600,430 - $960,290
-99,409 Reduced 35.77%
178,500 $1.34 Million
Q2 2022

Aug 15, 2022

BUY
$4.99 - $8.96 $323,895 - $581,584
64,909 Added 30.47%
277,909 $1.75 Million
Q1 2022

May 16, 2022

SELL
$3.84 - $9.74 $199,680 - $506,480
-52,000 Reduced 19.62%
213,000 $1.77 Million
Q4 2021

Feb 14, 2022

BUY
$5.12 - $8.19 $357,780 - $572,309
69,879 Added 35.81%
265,000 $1.38 Million
Q3 2021

Nov 15, 2021

BUY
$6.68 - $9.1 $264,180 - $359,886
39,548 Added 25.42%
195,121 $1.3 Million
Q2 2021

Aug 16, 2021

BUY
$7.82 - $9.23 $39,850 - $47,036
5,096 Added 3.39%
155,573 $1.33 Million
Q1 2021

May 17, 2021

BUY
$8.44 - $12.66 $182,548 - $273,823
21,629 Added 16.79%
150,477 $1.33 Million
Q4 2020

Feb 16, 2021

BUY
$7.98 - $12.29 $36,133 - $55,649
4,528 Added 3.64%
128,848 $1.58 Million
Q3 2020

Nov 16, 2020

SELL
$7.96 - $12.42 $244,212 - $381,045
-30,680 Reduced 19.79%
124,320 $1.01 Million
Q2 2020

Aug 14, 2020

BUY
$5.4 - $13.37 $73,720 - $182,527
13,652 Added 9.66%
155,000 $1.49 Million
Q1 2020

May 15, 2020

BUY
$4.91 - $14.7 $27,005 - $80,850
5,500 Added 4.05%
141,348 $961,000
Q4 2019

Feb 14, 2020

SELL
$9.77 - $15.66 $793,138 - $1.27 Million
-81,181 Reduced 37.41%
135,848 $2.02 Million
Q3 2019

Nov 14, 2019

SELL
$9.59 - $12.0 $1.52 Million - $1.91 Million
-159,006 Reduced 42.28%
217,029 $2.23 Million
Q2 2019

Aug 14, 2019

BUY
$9.54 - $14.96 $2.23 Million - $3.5 Million
233,895 Added 164.55%
376,035 $3.99 Million
Q1 2019

May 15, 2019

SELL
$10.31 - $14.38 $105,842 - $147,625
-10,266 Reduced 6.74%
142,140 $1.99 Million
Q4 2018

Feb 14, 2019

BUY
$8.63 - $12.4 $987,323 - $1.42 Million
114,406 Added 301.07%
152,406 $1.55 Million
Q3 2018

Nov 14, 2018

SELL
$9.6 - $12.9 $9,600 - $12,900
-1,000 Reduced 2.56%
38,000 $456,000
Q2 2018

Aug 14, 2018

BUY
$8.3 - $16.8 $323,700 - $655,200
39,000 New
39,000 $476,000

Others Institutions Holding EIGR

About Eiger BioPharmaceuticals, Inc.


  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $418M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Telemetry Investments, L.L.C. Portfolio

Follow Telemetry Investments, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.